CBIS - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Image for trademark with serial number 88045390
Serial Number
88045390
Word Mark
CBIS
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2020-08-25
Filing Date
2018-07-19
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
010905, 010925 - Atoms or molecular models. Other planets, asteroids, meteors.
Attorney Name
Law Office Assigned Location Code
L70
Employee Name
TRUSILO, KELLY JEAN
Statements
Indication of Colors claimed
The color(s) light green, dark green, brown, and white is/are claimed as a feature of the mark.
Description of Mark
The mark consists of a stylized molecule, which consists of 4 separate atoms, three of which are light green with a white border and brown outer ring, these three atoms are attached to a central dark green atom, which also has a white border and brown outer ring. The word "CBIS" is written in dark green to the right of the molecule.
Goods and Services
Research, and breeding services for medical purposes relating to Cannabis plants for the cannabinoid industry and research universities
Goods and Services
Organization and arrangement of educational and instructional seminars and conferences regarding legal, medical and political developments regarding cannabis and which do not include the provision or display of cannabis, cannabis-based preparations, or cannabis extracts or derivatives, synthetic cannabis, or other substances controlled by the Controlled Substances Act; Providing news in the field of current events reporting relating to legal, political and medical developments regarding cannabis
Goods and Services
Educational services, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, cancer treatment and cannabinoid medicines; instruction services in the field of pharmaceutical product development of medicines, cancer treatments and cannabinoid medicines
Goods and Services
Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Drug delivery agents that provide controlled release of the active ingredients for a wide variety of cannabinoid pharmaceuticals; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment and prevention of inflammatory bowel disease; Pharmaceutical preparations for use in gastroenterology; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Therapeutic pharmaceutical for the treatment and prevention of neurodegenerative disease; Therapeutic pharmaceutical for the treatment and prevention of neurological disorders; Pharmaceutical preparations for use in neurology; Pharmaceutical preparations and substances for the treatment and prevention of psychiatric diseases and disorders; Therapeutic pharmaceutical for the treatment and prevention of autoimmune conditions; Therapeutic pharmaceutical for the treatment and prevention of inflammation; Pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; Therapeutic pharmaceutical for the treatment and prevention of pain; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Therapeutic pharmaceutical for the treatment of infections; Therapeutic pharmaceutical for the treatment of drug-resistant infections; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical agents affecting sensory organs; Analgesic and muscle relaxant pharmaceutical preparations; Pharmaceutical preparations for use in urology; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in opthalmology; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations for skin care; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Ocular pharmaceuticals; Antibacterial pharmaceuticals; Pharmaceuticals, namely, anti-infectives
Goods and Services
Scientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, cancer treatment and cannabinoid medicine development, and research and new product design services relating thereto; chemical analysis; chemical research; research and development in the field of medicines, healthcare, cancer treatment and cannabinoid medicines
Goods and Services
Medical services, namely, medical analysis of neuropathic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, Alzheimer's, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse and autism
Goods and Services
Scientific and medical research, laboratory research services, and testing for scientific research purposes related to Cannabis; consulting services in the fields of biotechnology, pharmaceutical research and development, genetic science, and laboratory tests; providing information about research and development related to Cannabis on a global computer network; genetic and genomic testing and research for scientific research purposes relating to Cannabis plants for the cannabinoid industry and research universities
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-07-26
Primary Code
005
First Use Anywhere Date
2009-05-07
First Use In Commerce Date
2009-05-07
Correspondences
Name
Faiyaz Dean
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2018-07-26NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-07-27NOTICE OF DESIGN SEARCH CODE E-MAILED
2018-08-07ASSIGNED TO EXAMINER
2019-06-20ASSIGNED TO EXAMINER
2019-06-25NON-FINAL ACTION WRITTEN
2019-06-25NON-FINAL ACTION E-MAILED
2019-06-25NOTIFICATION OF NON-FINAL ACTION E-MAILED
2019-12-24TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-01-14ASSIGNED TO LIE
2020-01-14CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-01-14TEAS/EMAIL CORRESPONDENCE ENTERED
2020-02-12NON-FINAL ACTION WRITTEN
2020-02-12NON-FINAL ACTION E-MAILED
2020-02-12NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-08-25ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
2020-08-25ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND